Matthew Cortese, MD, MPH (@matt_cortese) 's Twitter Profile
Matthew Cortese, MD, MPH

@matt_cortese

Asst Prof of Oncology/Lymphoma @RoswellPark | Proud Husband/Father | @ClevelandClinic @UCincyIM @UpstateNews & @Cornell alum | Tweets/views my own. He/Him.

ID: 931278517

linkhttps://www.roswellpark.org/matthew-cortese calendar_today07-11-2012 05:08:33

1,1K Tweet

1,1K Followers

2,2K Following

Khushali Jhaveri (@jhaverikhushali) 's Twitter Profile Photo

🧠7y MARIETTA update in SCNSL PFS 33% in pts <70 (MATRIX/RICE ± ASCT) Best PFS in tx-naïve (52%), isolated CNS relapse (33%), synchronous (11%) Resp after 2cy → better outcomes Auto-SCT → PFS (64%) IT chemo → better PFS (p=0.017) Trend: single CNS site = better PFS #ICML2025

🧠7y MARIETTA update in SCNSL
PFS 33% in pts &lt;70 (MATRIX/RICE ± ASCT)
Best PFS in tx-naïve (52%), isolated CNS relapse (33%), synchronous (11%)
Resp after 2cy → better outcomes
Auto-SCT → PFS (64%)
IT chemo → better PFS (p=0.017)
Trend: single CNS site = better PFS
#ICML2025
Matthew Cortese, MD, MPH (@matt_cortese) 's Twitter Profile Photo

Excited to “Ride for Roswell” with my Lymphoma colleagues to fund our cancer research in light of recent cuts. Support appreciated if able! Roswell Park give.roswellpark.org/site/TR/Specia…

ACIR (@acir_org) 's Twitter Profile Photo

Mutant p53 doesn’t just lose functionality as a tumor suppressor - it gains new functions that promote an immunosuppressive microenvironment bit.ly/40HZR9s  Koch Institute at MIT  Mass General Imaging

Mutant p53 doesn’t just lose functionality as a tumor suppressor - it gains new functions that promote an immunosuppressive microenvironment bit.ly/40HZR9s  <a href="/kochinstitute/">Koch Institute at MIT</a>  <a href="/MGHImaging/">Mass General Imaging</a>
Matthew Cortese, MD, MPH (@matt_cortese) 's Twitter Profile Photo

Very proud of my Cleveland Clinic mentor Dr. Brian Hill and former co-fellow Dr Taylor Brooks (Roswell Park contributed) and their large study on outcomes with BSAbs in #DLBCL. Great option but more research greatly needed especially post #CART #lymsm

Michael Wang, MD (@michaelwangmd) 's Twitter Profile Photo

This article was epublished in an high impact journal “Blood” last week. It is a brand new approach to drug resistance! We thank all people who support our research!

Ajay Major, MD, MBA (@majorajay) 's Twitter Profile Photo

Survival after incidental vs symptomatic FL: - 908 pts, 29% incidental - incidental: more early stage & normal LDH - no diff in EFS, lymphoma-specific survival, or OS between groups We can answer the "what if this was picked up earlier" question! #lymsm nature.com/articles/s4140…

Survival after incidental vs symptomatic FL:
- 908 pts, 29% incidental
- incidental: more early stage &amp; normal LDH
- no diff in EFS, lymphoma-specific survival, or OS between groups
We can answer the "what if this was picked up earlier" question! #lymsm
nature.com/articles/s4140…
Nick Mark MD (@nickmmark) 's Twitter Profile Photo

This will be absolutely devastating in the medical field. ~30% residents are international medical graduates & ~10k of 43k residency spots are filled by docs with H1-B visas. Previously the h-1B fee was <$5,000. No hospital will pay a $100k fee for a $55k resident salary.

Daniel Di Martino 🇺🇸🇻🇪 (@danieldimartino) 's Twitter Profile Photo

SUMMARY OF H-1B EXECUTIVE ORDER - ENTRY BAN: No H-1B visa holder may enter the United States beginning Sunday September 21st, including current visa holders, unles they pay $100K to enter. - VISA FEE: New H-1B and H-1B extensions must pay 100K to be processed and 100K per year